These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 22333264

  • 1. Clinical decision support of therapeutic drug monitoring of phenytoin: measured versus adjusted phenytoin plasma concentrations.
    Krasowski MD, Penrod LE.
    BMC Med Inform Decis Mak; 2012 Feb 14; 12():7. PubMed ID: 22333264
    [Abstract] [Full Text] [Related]

  • 2. Free phenytoin assessment in patients: measured versus calculated blood serum levels.
    Tobler A, Hösli R, Mühlebach S, Huber A.
    Int J Clin Pharm; 2016 Apr 14; 38(2):303-9. PubMed ID: 26746902
    [Abstract] [Full Text] [Related]

  • 3. Serum albumin-adjusted phenytoin levels: an approach for predicting drug efficacy in patients with epilepsy, suitable for developing countries.
    Tandon M, Pandhi P, Garg SK, Prabhakar SK.
    Int J Clin Pharmacol Ther; 2004 Oct 14; 42(10):550-5. PubMed ID: 15516024
    [Abstract] [Full Text] [Related]

  • 4. Total phenytoin concentrations do not accurately predict free phenytoin concentrations in critically ill children.
    Wolf GK, McClain CD, Zurakowski D, Dodson B, McManus ML.
    Pediatr Crit Care Med; 2006 Sep 14; 7(5):434-9; quiz 440. PubMed ID: 16885794
    [Abstract] [Full Text] [Related]

  • 5. Differences between the measured and calculated free serum phenytoin concentrations in epileptic patients.
    Hong JM, Choi YC, Kim WJ.
    Yonsei Med J; 2009 Aug 31; 50(4):517-20. PubMed ID: 19718399
    [Abstract] [Full Text] [Related]

  • 6. Predicting Unbound Phenytoin Concentrations: Effects of Albumin Concentration and Kidney Dysfunction.
    Montgomery MC, Chou JW, McPharlin TO, Baird GS, Anderson GD.
    Pharmacotherapy; 2019 Jul 31; 39(7):756-766. PubMed ID: 31067355
    [Abstract] [Full Text] [Related]

  • 7. Correlation of Free and Total Phenytoin Serum Concentrations in Critically Ill Patients.
    Buckley MS, Reeves BA, Barletta JF, Bikin DS.
    Ann Pharmacother; 2016 Apr 31; 50(4):276-81. PubMed ID: 26783351
    [Abstract] [Full Text] [Related]

  • 8. Plasma total phenytoin: a possibly misleading test in developing countries.
    Fedler C, Stewart MJ.
    Ther Drug Monit; 1999 Apr 31; 21(2):155-60. PubMed ID: 10217333
    [Abstract] [Full Text] [Related]

  • 9. Predicting unbound phenytoin concentrations in the critically ill neurosurgical patient.
    Mlynarek ME, Peterson EL, Zarowitz BJ.
    Ann Pharmacother; 1996 Mar 31; 30(3):219-23. PubMed ID: 8833553
    [Abstract] [Full Text] [Related]

  • 10. Comparisons of Four Protein-Binding Models Characterizing the Pharmacokinetics of Unbound Phenytoin in Adult Patients Using Non-Linear Mixed-Effects Modeling.
    Jun H, Rong Y, Yih C, Ho J, Cheng W, Kiang TKL.
    Drugs R D; 2020 Dec 31; 20(4):343-358. PubMed ID: 33026608
    [Abstract] [Full Text] [Related]

  • 11. Estimation of Free Phenytoin Concentration in Critically Ill Patients with Hypoalbuminemia: Direct-measurement vs Traditional Equations.
    Wilfred PM, Mathew S, Chacko B, Prabha R, Mathew BS.
    Indian J Crit Care Med; 2022 Jun 31; 26(6):682-687. PubMed ID: 35836626
    [Abstract] [Full Text] [Related]

  • 12. Characterization of unbound phenytoin concentrations in neurointensive care unit patients using a revised Winter-Tozer equation.
    Kane SP, Bress AP, Tesoro EP.
    Ann Pharmacother; 2013 May 31; 47(5):628-36. PubMed ID: 23606554
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic Drug Monitoring of Phenytoin by Simple, Rapid, Accurate, Highly Sensitive and Novel Method and Its Clinical Applications.
    Shaikh AS, Guo R.
    Curr Pharm Biotechnol; 2017 May 31; 18(13):1098-1105. PubMed ID: 29437004
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G, Malla S, Shakya KN, Shrestha R.
    JNMA J Nepal Med Assoc; 2008 May 31; 47(171):94-7. PubMed ID: 19079370
    [Abstract] [Full Text] [Related]

  • 15. Estimating phenytoin concentrations by the Sheiner-Tozer method in adults with pronounced hypoalbuminemia.
    Dager WE, Inciardi JF, Howe TL.
    Ann Pharmacother; 1995 May 31; 29(7-8):667-70. PubMed ID: 8520077
    [Abstract] [Full Text] [Related]

  • 16. Nonlinear protein binding of phenytoin in clinical practice: Development and validation of a mechanistic prediction model.
    Ter Heine R, Kane SP, Huitema ADR, Krasowski MD, van Maarseveen EM.
    Br J Clin Pharmacol; 2019 Oct 31; 85(10):2360-2368. PubMed ID: 31269540
    [Abstract] [Full Text] [Related]

  • 17. Clinical evaluation of plasma free phenytoin measurement and factors influencing its protein binding.
    Iwamoto T, Kagawa Y, Naito Y, Kuzuhara S, Okuda M.
    Biopharm Drug Dispos; 2006 Mar 31; 27(2):77-84. PubMed ID: 16308884
    [Abstract] [Full Text] [Related]

  • 18. Free phenytoin concentration measurement in brain extracellular fluid: a pilot study.
    Tisdall M, Russo S, Sen J, Belli A, Ratnaraj N, Patsalos P, Petzold A, Kitchen N, Smith M.
    Br J Neurosurg; 2006 Oct 31; 20(5):285-9. PubMed ID: 17129875
    [Abstract] [Full Text] [Related]

  • 19. A Comprehensive Review on the Predictive Performance of the Sheiner-Tozer and Derivative Equations for the Correction of Phenytoin Concentrations.
    Kiang TK, Ensom MH.
    Ann Pharmacother; 2016 Apr 31; 50(4):311-25. PubMed ID: 26825643
    [Abstract] [Full Text] [Related]

  • 20. Revised Winter-Tozer equation for normalized phenytoin concentrations in trauma and elderly patients with hypoalbuminemia.
    Anderson GD, Pak C, Doane KW, Griffy KG, Temkin NR, Wilensky AJ, Winn HR.
    Ann Pharmacother; 1997 Mar 31; 31(3):279-84. PubMed ID: 9066931
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.